Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

392
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
392
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

565
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
565
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

629
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
629
Pharmacovigilance01:19

Pharmacovigilance

1.3K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.3K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

861
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
861
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

326
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
326

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of progression of asymptomatic severe aortic stenosis using Apple Watch-estimated maximal oxygen consumption (VO<sub>2</sub> max): a case report.

European heart journal. Case reports·2026
Same author

Epinephrine and the paradox of Kounis syndrome: a case series and review of management.

European heart journal. Case reports·2025
Same author

Transcatheter Edge-to-Edge Repair of Severe Tricuspid Regurgitation With a Large Coaptation Gap Facilitated by VA-ECMO.

JACC. Cardiovascular interventions·2025
Same author

Antidepressants and Lung Toxicity: A Narrative Review.

Cureus·2025
Same author

Procedure-related cerebral air embolism: Systematic review and individual participant data meta-analysis.

Clinical neurology and neurosurgery·2025
Same author

Unique North American isolates of severe metastatic hypervirulent Klebsiella pneumoniae strain infections with hepatic abscesses seen in young patients within Texas.

PloS one·2025

Related Experiment Video

Updated: Nov 2, 2025

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
06:58

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

19.5K

Ceftaroline-Associated Encephalopathy: A Rare Adverse Effect.

Aswin Srinivasan1, Blake Bennie2, Krina Viroliya1

  • 1Internal Medicine, HCA Houston Kingwood/University of Houston College of Medicine, Kingwood, USA.

Cureus
|June 7, 2021
PubMed
Summary

Ceftaroline can cause encephalopathy, a brain dysfunction, particularly in patients with reduced kidney function. Symptoms resolved after stopping the antibiotic, highlighting the need for careful monitoring.

Keywords:
ceftarolineencephalopathy

More Related Videos

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
09:16

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury

Published on: June 21, 2019

25.9K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

836

Related Experiment Videos

Last Updated: Nov 2, 2025

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
06:58

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

19.5K
Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
09:16

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury

Published on: June 21, 2019

25.9K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

836

Area of Science:

  • Pharmacology
  • Neurology
  • Infectious Diseases

Background:

  • Ceftaroline is a cephalosporin antibiotic used for acute bacterial skin and skin structure infections (aBSSSIs).
  • Antibiotic-associated encephalopathy is a rare but serious adverse effect.
  • Renal impairment can affect drug clearance and increase the risk of toxicity.

Observation:

  • A case of a patient experiencing encephalopathy while undergoing treatment with ceftaroline for aBSSSIs.
  • The patient's neurological symptoms improved significantly after the discontinuation of ceftaroline.
  • The patient had a creatinine clearance (CrCl) below 50 mL/min.

Findings:

  • Ceftaroline administration was associated with the development of encephalopathy.
  • Cessation of ceftaroline led to the resolution of encephalopathic symptoms.
  • Reduced kidney function (CrCl <50 mL/min) may be a risk factor for ceftaroline-associated encephalopathy.

Implications:

  • Clinicians should consider ceftaroline-associated encephalopathy in patients presenting with neurological symptoms during treatment.
  • Close monitoring for encephalopathy is recommended in patients with impaired renal function (CrCl <50 mL/min) receiving ceftaroline.
  • This case highlights the importance of considering drug-induced neurological adverse events, especially in vulnerable patient populations.